Suivre
François Mullier
Titre
Citée par
Citée par
Année
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
93962018
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ...
Journal of extracellular vesicles 13 (2), e12404, 2024
7702024
Impact of dabigatran on a large panel of routine or specific coagulation assays
J Douxfils, F Mullier, S Robert, C Chatelain, B Chatelain, JM Dogné
Thrombosis and Haemostasis 107 (5), 985-97, 2012
4692012
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
J Douxfils, W Ageno, CM Samama, S Lessire, H Ten Cate, P Verhamme, ...
Journal of Thrombosis and Haemostasis 16 (2), 209-219, 2018
3872018
EVpedia: a community web portal for extracellular vesicles research
DK Kim, J Lee, SR Kim, DS Choi, YJ Yoon, JH Kim, G Go, D Nhung, ...
Bioinformatics 31 (6), 933-939, 2015
3842015
Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC …
R Lacroix, S Robert, P Poncelet, RS Kasthuri, NS Key, F Dignat‐George
Journal of Thrombosis and Haemostasis 8 (11), 2571-2574, 2010
3662010
Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature
J Douxfils, F Mullier, C Loosen, C Chatelain, B Chatelain, JM Dogné
Thrombosis research 130 (6), 956-966, 2012
2932012
Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
J Douxfils, C Chatelain, B Chatelain, JM Dogné, F Mullier
Thrombosis and Haemostasis 110 (2), 2013
2642013
D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
J Favresse, G Lippi, PM Roy, B Chatelain, H Jacqmin, H Ten Cate, ...
Critical reviews in clinical laboratory sciences 55 (8), 548-577, 2018
2212018
Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: a systematic …
J Douxfils, H Haguet, F Mullier, C Chatelain, C Graux, JM Dogne
JAMA oncology 2 (5), 625-632, 2016
2022016
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban
J Douxfils, A Tamigniau, B Chatelain, C Chatelain, P Wallemacq, ...
Thrombosis and haemostasis 110 (10), 723-731, 2013
1852013
Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories
A Magnette, M Chatelain, B Chatelain, H Ten Cate, F Mullier
Thrombosis journal 14, 1-14, 2016
1802016
Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation
E van der Pol, A Sturk, T van Leeuwen, R Nieuwland, F Coumans, ...
Journal of thrombosis and haemostasis 16 (6), 1236-1245, 2018
1722018
Antibody titres decline 3-month post-vaccination with BNT162b2
J Favresse, JL Bayart, F Mullier, M Elsen, C Eucher, S Van Eeckhoudt, ...
Emerging microbes & infections 10 (1), 1495-1498, 2021
1662021
Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
A Godier, AS Dincq, AC Martin, A Radu, I Leblanc, M Antona, M Vasse, ...
European heart journal 38 (31), 2431-2439, 2017
1562017
Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate
J Douxfils, JM Dogné, F Mullier, B Chatelain, Y Rönquist-Nii, ...
Thrombosis and haemostasis 110 (09), 543-549, 2013
1442013
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review
B Devalet, F Mullier, B Chatelain, JM Dogné, C Chatelain
European journal of haematology 95 (3), 190-198, 2015
1392015
Impact of silver nanoparticles on haemolysis, platelet function and coagulation
J Laloy, V Minet, L Alpan, F Mullier, S Beken, O Toussaint, S Lucas, ...
Nanobiomedicine 1, 4, 2014
1252014
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all‐cause mortality: a systematic review and meta‐analysis of …
J Douxfils, F Buckinx, F Mullier, V Minet, V Rabenda, JY Reginster, ...
Journal of the American Heart Association 3 (3), e000515, 2014
1252014
Perioperative management of patients on direct oral anticoagulants
V Dubois, AS Dincq, J Douxfils, B Ickx, CM Samama, JM Dogné, ...
Thrombosis Journal 15, 1-17, 2017
1242017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20